---
figid: PMC5422801__pnas.1703096114fig06
figlink: /pmc/articles/PMC5422801/figure/fig06/
number: Fig. 6
caption: Hippo–YAP pathway mediates physiological resistance to gemcitabine. In low-crowding
  conditions or in the case of Hippo pathway genetic aberrations, Hippo pathway is
  inactive, leading to lower levels of CDA and efflux pumps. This increases intracellular
  concentration of gemcitabine causing enhanced killing. In high-crowding conditions,
  Hippo pathway is active, leading to higher levels of CDA and efflux pumps. This
  reduces intracellular concentration of gemcitabine, leading to drug resistance.
pmcid: PMC5422801
papertitle: Hippo pathway mediates resistance to cytotoxic drugs.
reftext: Taranjit S. Gujral, et al. Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3729-E3738.
pmc_ranked_result_index: '22850'
pathway_score: 0.9619502
filename: pnas.1703096114fig06.jpg
figtitle: Hippo–YAP pathway mediates physiological resistance to gemcitabine
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5422801__pnas.1703096114fig06.html
  '@type': Dataset
  description: Hippo–YAP pathway mediates physiological resistance to gemcitabine.
    In low-crowding conditions or in the case of Hippo pathway genetic aberrations,
    Hippo pathway is inactive, leading to lower levels of CDA and efflux pumps. This
    increases intracellular concentration of gemcitabine causing enhanced killing.
    In high-crowding conditions, Hippo pathway is active, leading to higher levels
    of CDA and efflux pumps. This reduces intracellular concentration of gemcitabine,
    leading to drug resistance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LATS1
  - STK11
  - SGMS1
  - LATS2
  - MST1
  - MERTK
  - CDA
  - YY1AP1
  - CTGF
  - STK3
  - SLC29A2
  - AMOTL2
  - DCK
  - SLC29A1
  - Gemcitabine
  - dFdCMP
genes:
- word: LATS1/2
  symbol: LATS1
  source: hgnc_symbol
  hgnc_symbol: LATS1
  entrez: '9113'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: Mob
  symbol: MOB
  source: hgnc_alias_symbol
  hgnc_symbol: SGMS1
  entrez: '259230'
- word: LATS1/2
  symbol: LATS2
  source: hgnc_symbol
  hgnc_symbol: LATS2
  entrez: '26524'
- word: MST1/2
  symbol: MST1
  source: hgnc_symbol
  hgnc_symbol: MST1
  entrez: '4485'
- word: Mer
  symbol: mer
  source: hgnc_alias_symbol
  hgnc_symbol: MERTK
  entrez: '10461'
- word: CDA
  symbol: CDA
  source: hgnc_symbol
  hgnc_symbol: CDA
  entrez: '978'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: CTGF,
  symbol: CTGF
  source: hgnc_symbol
  hgnc_symbol: CTGF
  entrez: '1490'
- word: MST1/2
  symbol: MST2
  source: hgnc_alias_symbol
  hgnc_symbol: STK3
  entrez: '6788'
- word: ENT1/2
  symbol: ENT2
  source: hgnc_prev_symbol
  hgnc_symbol: SLC29A2
  entrez: '3177'
- word: AMOTL2
  symbol: AMOTL2
  source: hgnc_symbol
  hgnc_symbol: AMOTL2
  entrez: '51421'
- word: dCK
  symbol: DCK
  source: hgnc_symbol
  hgnc_symbol: DCK
  entrez: '1633'
- word: ENT1/2
  symbol: ENT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC29A1
  entrez: '2030'
chemicals:
- word: Gemcitabine
  source: MESH
  identifier: C056507
- word: dFdCMP
  source: MESH
  identifier: C061556
diseases: []
---
